Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.68 +0.03 (+0.82%)
At close: Sep 30, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Current Deferred Revenue (2018 - 2026)

Updated

Bicycle Therapeutics (BCYC) recorded Current Deferred Revenue of $2.88 million in Q2 2026, down 80.3% from $14.62 million a year earlier but up 3.0% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Current Deferred Revenue (2018 - 2026) Analysis & Trends

At the end of FY2025, Bicycle Therapeutics reported Current Deferred Revenue of $2.96 million, down 70.9% from FY2024.

  • Annual Current Deferred Revenue has a five-year compound annual growth rate of -21.8% (FY2020 to FY2025).
  • Across earlier years, Current Deferred Revenue came in at $10.19 million in FY2024 (-59.2%), $24.98 million in FY2023 (+22.3%), $20.42 million in FY2022 (+5.9%) and $19.27 million in FY2021 (+90.2%).
  • Quarterly Current Deferred Revenue has ranged from $2.8 million in Q1 2026 to $29.75 million in Q2 2023 over the past five years.
  • On a year-over-year basis, Current Deferred Revenue has declined for three consecutive quarters, with an average decline of 42.1% over the last eight quarters.
  • Peak year-over-year performance for Current Deferred Revenue in the last five years was growth of 142.8% in Q3 2021, against a decline of 80.3% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.8 million (Q1 2026), $2.96 million (Q4 2025) and $12.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bicycle Therapeutics 256.92 Mn 256.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.88 Mn
Mar 31, 2026 2.80 Mn
Dec 31, 2025 2.96 Mn
Sep 30, 2025 12.26 Mn
Jun 30, 2025 14.62 Mn
Mar 31, 2025 12.52 Mn
Dec 31, 2024 10.19 Mn
Sep 30, 2024 11.38 Mn
Jun 30, 2024 11.62 Mn
Mar 31, 2024 16.42 Mn
Dec 31, 2023 24.98 Mn
Sep 30, 2023 27.19 Mn
Jun 30, 2023 29.75 Mn
Mar 31, 2023 24.97 Mn
Dec 31, 2022 20.42 Mn
Sep 30, 2022 16.40 Mn
Jun 30, 2022 19.53 Mn
Mar 31, 2022 19.15 Mn
Dec 31, 2021 19.27 Mn
Sep 30, 2021 17.46 Mn
API Access

Bicycle Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BCYC&period=max&api_key=YOUR_API_KEY